We are live on ! Find out more
PCM

Pentwater Capital Management Portfolio holdings

AUM $19.3B
1-Year Est. Return 58.13%
This Fund
S&P 500
This Quarter Est. Return
+14.05%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$12.1B
AUM Growth
+$1.64B
Cap. Flow
+$978M
Cap. Flow %
8.07%
Top 10 Hldgs %
60.36%
Holding
446
New
110
Increased
68
Reduced
64
Closed
143

Sector Composition

Rank Sector Weight
1 Technology 19.76%
2 Healthcare 16.44%
3 Communication Services 8.82%
4 Industrials 6.64%
5 Consumer Discretionary 4.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASO icon
101
Academy Sports + Outdoors
ASO
$2.98B
$4.87M 0.04%
118,000
+18,000
+18% +$631K
TELA icon
102
TELA Bio
TELA
$38.9M
$4.86M 0.04%
301,834
+26,834
+10% +$368K
SYF icon
103
CALL
Synchrony
SYF
$25.6B
$4.85M 0.04%
100,000
-420,000
-81% -$19.1M
HOME
104
DELISTED
At Home Group Inc.
HOME
$4.72M 0.04%
+128,200
New +$4.37M
GTM
105
ZoomInfo Technologies
GTM
$1.22B
$4.7M 0.04%
90,000
+33,000
+58% +$1.55M
PTOC
106
DELISTED
Pine Technology Acquisition Corp. Class A Common Stock
PTOC
$4.6M 0.04%
+474,993
New +$4.63M
GIGGU
107
DELISTED
GigCapital4, Inc. Unit
GIGGU
$4.59M 0.04%
+449,200
New +$4.51M
SNOW icon
108
Snowflake
SNOW
$115B
$4.35M 0.04%
18,000
-2,000
-10% -$465K
ESPR
109
CALL
DELISTED
Esperion Therapeutics
ESPR
$4.23M 0.03%
+200,000
New +$4.82M
NVTS icon
110
Navitas Semiconductor
NVTS
$3.63B
$4.18M 0.03%
+421,600
New +$4.21M
OPCH icon
111
Option Care Health
OPCH
$3.56B
$4.11M 0.03%
188,122
-306,878
-62% -$5.92M
XOG
112
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
$3.91M 0.03%
+71,184
New +$3.37M
STRO icon
113
Sutro Biopharma
STRO
$421M
$3.9M 0.03%
21,000
+2,550
+14% +$499K
COLD icon
114
Americold
COLD
$4.27B
$3.79M 0.03%
100,000
WMB icon
115
Williams Companies
WMB
$86.1B
$3.72M 0.03%
140,000
-20,000
-13% -$512K
RDWR icon
116
Radware
RDWR
$1.19B
$3.69M 0.03%
+120,000
New +$3.46M
ACCD
117
DELISTED
Accolade Inc
ACCD
$3.67M 0.03%
67,500
-2,500
-4% -$121K
REGN icon
118
Regeneron Pharmaceuticals
REGN
$80.8B
$3.63M 0.03%
6,500
LESL icon
119
Leslie's
LESL
$11M
$3.57M 0.03%
6,500
+3,375
+108% +$1.85M
DIN icon
120
Dine Brands
DIN
$452M
$3.57M 0.03%
40,000
-98,800
-71% -$9.14M
UBER icon
121
Uber
UBER
$153B
$3.51M 0.03%
+70,000
New +$3.66M
ARVN icon
122
Arvinas
ARVN
$572M
$3.43M 0.03%
44,600
AVTR icon
123
Avantor
AVTR
$9.19B
$3.37M 0.03%
95,000
-79,500
-46% -$2.57M
RAPT
124
DELISTED
RAPT Therapeutics
RAPT
$3.34M 0.03%
13,125
+9,375
+250% +$1.75M
HUYA
125
Huya Inc
HUYA
$558M
$3.18M 0.03%
180,000
-515,600
-74% -$8.64M

Similar funds

Pentwater Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Pentwater Capital Management held 446 positions worth $12.1B, up 16% from $10.5B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Pentwater Capital Management deployed $978M of net new capital in Q2 2021, opening 110 new positions and adding to 68 existing holdings. Its largest new stake was Nuance Communications, Inc.: 12,230,000 shares worth $666M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Xilinx Inc, an estimated $481M trimmed.

  • Pentwater Capital Management's largest Q2 2021 buy was Nuance Communications, Inc.: 12,230,000 shares worth $666M.
  • Pentwater Capital Management added most to PPD, Inc. Common Stock in Q2 2021, an estimated $547M increase.
  • Pentwater Capital Management's biggest Q2 2021 reduction was Xilinx Inc, cutting an estimated $481M.
  • Pentwater Capital Management fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $456M.
  • Pentwater Capital Management's ten largest holdings make up 60% of its $12.1B portfolio in Q2 2021.
  • Pentwater Capital Management opened 110 new positions and closed 143 in Q2 2021.
  • Pentwater Capital Management's portfolio value rose 16% quarter-over-quarter to $12.1B.

Based on Pentwater Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.